NCT04742478

Brief Summary

Rotablation with or without other calcium debulking therapies is a safe adjunctive procedure for patients with severe coronary calcification requiring Percutaneous Coronary Intervention (PCI).

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Mar 2021Dec 2026

First Submitted

Initial submission to the registry

February 2, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 8, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2024

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 23, 2021

Status Verified

April 1, 2021

Enrollment Period

3 years

First QC Date

February 2, 2021

Last Update Submit

April 21, 2021

Conditions

Keywords

Atherosclerotic CalcificationMedial Artery CalcificationRotational Atherectomy

Outcome Measures

Primary Outcomes (1)

  • Primary efficacy endpoint (Procedural success)

    Procedural success defined as \< 20% residual stenosis in treated segment without on-table mortality with TIMI 3 flow.

    Duration of procedure

Secondary Outcomes (5)

  • Death

    1 year

  • Periprocedural myocardial infarction (MI)

    within 48 hours of procedure

  • Complications

    within 48 hours of procedure

  • Complication

    within 48 hours of procedure

  • Procedural time

    Duration of procedure

Study Arms (2)

Eligible subjects who underwent RA prior to PCI (with informed consent taken to join the study)

Informed consent to be obtained either prior to PCI with rotational atherectomy planned or within 48 hours after rotational atherectomy. There will be data collection of history/demographics, laboratory results, symptoms, any serious adverse events recording for this cohort as well as a telephone follow up at 12months post rotational atherectomy.

Procedure: Rotational Atherectomy

Eligible subjects who underwent RA prior to PCI (without informed consent taken to join the study)

Subjects that were demised or refused to give consent will fall under this cohort. The data collection of this cohort will be done through screening of in-hospital data via available local PCI database/registry.

Procedure: Rotational Atherectomy

Interventions

Rotational atherectomy (RA) has been the most used atherectomy modality since its first inception in1988. RA uses high speed rotation (140,000 - 180,000 rpm) to ablate inelastic plaque, resulting in debris averaging 5µm in size24. The main focus of RA in the era of DES stent has been on plaque modification rather that plaque debulking with more papers showing improved PCI success rates.

Eligible subjects who underwent RA prior to PCI (with informed consent taken to join the study)Eligible subjects who underwent RA prior to PCI (without informed consent taken to join the study)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with signed informed consent for percutaneous coronary intervention (PCI) and are eligible for calcium debulking treatment with rotational atherectomy with or without other forms of calcium debulking therapies will be enrolled into this study.

You may qualify if:

  • Able to understand and sign an informed consent form
  • Presence of clinical indication for percutaneous coronary intervention (PCI) and/or stent placement
  • Subjects willing to comply with all research and follow-up requirements.
  • Angiographic criteria (ONE of the following criteria MUST be met)
  • Target lesions visually have at least moderate calcifications\*
  • Target lesion balloon dilatation failure
  • Inability of devices (microcatheters, balloons or stents) to pass through the target lesion.
  • Procedural criteria
  • All patients treated with RA with or without other forms of debulking therapy
  • Moderate calcification is defined as radio-opacities noted only during cardiac cycle prior to contrast injection whereas severe calcification is defined as radio-opacities seen without cardiac motion prior to contrast injection, usually affecting both sides of the arterial lumen.

You may not qualify if:

  • Decline to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kokura Memorial hospital

Kitakyushu, 802-8555, Japan

RECRUITING

National Heart Centre Singapore

Singapore, 169609, Singapore

RECRUITING

Related Publications (2)

  • Lee MS, Park KW, Shlofmitz E, Shlofmitz RA. Comparison of Rotational Atherectomy Versus Orbital Atherectomy for the Treatment of Heavily Calcified Coronary Plaques. Am J Cardiol. 2017 May 1;119(9):1320-1323. doi: 10.1016/j.amjcard.2017.01.025. Epub 2017 Feb 10.

    PMID: 28258729BACKGROUND
  • Sharma SK, Tomey MI, Teirstein PS, Kini AS, Reitman AB, Lee AC, Genereux P, Chambers JW, Grines CL, Himmelstein SI, Thompson CA, Meredith IT, Bhave A, Moses JW. North American Expert Review of Rotational Atherectomy. Circ Cardiovasc Interv. 2019 May;12(5):e007448. doi: 10.1161/CIRCINTERVENTIONS.118.007448.

    PMID: 31084239BACKGROUND

MeSH Terms

Interventions

Atherectomy, Coronary

Intervention Hierarchy (Ancestors)

AtherectomyAngioplastyCatheterizationTherapeuticsMyocardial RevascularizationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeEndovascular ProceduresVascular Surgical ProceduresPercutaneous Coronary InterventionMinimally Invasive Surgical ProceduresThoracic Surgical ProceduresInvestigative Techniques

Study Officials

  • Khung Keong Yeo

    Singhealth Foundation

    PRINCIPAL INVESTIGATOR
  • Shoichi Kuramitsu

    Kokura Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2021

First Posted

February 8, 2021

Study Start

March 10, 2021

Primary Completion

February 29, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

April 23, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations